MedPath

An Open Label Single Arm Clinical Study To Evaluate The Combined Effect of Virechana And Trayantyadi Kashaya In Alcoholic Liver Disease

Phase 2
Conditions
Health Condition 1: K709- Alcoholic liver disease, unspecified
Registration Number
CTRI/2023/07/054967
Lead Sponsor
Dr Rakshith MM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.subjects having Alcohol dependence 1 year or more

2.Subjects full filling the diagnostic criteria

3.Subjects with or with out raised billirubin levl (0.1-10 mg/dl )

4.Subjects not suffering from Alcoholic withdrawal symptoms

5.Subjects between the age group of 20-60 years irrespective of gender

6.Subjects with elevated LFT values

Exclusion Criteria

1.Subjects diagnosed with HIV, HBV, Tuberculosis, Myocardial infarction, other systemic diseases which interfere with the course of treatment.

2.Subjects diagnosed with Cirrhosis of liver, Ascites, Viral hepatitis, Severe Alcoholic Hepatitis, and other Psychiatric diseases which interfere with the course of treatment.

3.Subjects diagnosed with other Psychoactive drug dependance.

4.Subjects under active administration of hepato-toxic drugs.

5.Pregnant Women and Lactating Mothers.

6.Subjects not fit for Virechana.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath